Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8

Explore clinical trials studying Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

8 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8 trial results

Recruiting

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

NCT04329494

Conditions: Abdominal Neoplasms, Adnexal Diseases, Appendiceal Neoplasms, +62 more
Locations: City of Hope Medical Center Duarte, California, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Northwell Health Cancer Institute at Huntington Greenlawn, New York, United States

View Trial Details

Recruiting

Intravital Microscopy in Human Solid Tumors

NCT03823144

Conditions: Adenocarcinoma, Anatomic Stage IV Breast Cancer AJCC v8, Brain Diseases, +57 more
Locations: Mayo Clinic Florida Jacksonville, Florida, United States

View Trial Details

Recruiting

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

NCT04221893

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Anal Canal Carcinoma, +72 more
Locations: University of California, San Francisco San Francisco, California, United States

John Muir Medical Center-Walnut Creek Walnut Creek, California, United States

View Trial Details

Completed

Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Adenocarcinoma

NCT03395847

Conditions: Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, +22 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Cancer

NCT03918499

Conditions: Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IVA Gastric Cancer AJCC v8, +15 more
Locations: HonorHealth Research Institute Scottsdale, Arizona, United States

City of Hope Medical Center Duarte, California, United States

Texas Oncology at Baylor Charles A Sammons Cancer Center Dallas, Texas, United States

View Trial Details

Active, Not Recruiting

Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma

NCT05041153

Conditions: Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Gastric Cancer AJCC v8, +30 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events

NCT05038254

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +71 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer

NCT04220827

Conditions: Abdominal Neoplasms, Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, +21 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8

Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8 trial results

Related conditions